Section of Nephrology, Division of Internal Medicine, The University of Texas at MD Anderson Cancer Center, Houston, Texas, USA.
Section of Nephrology, Division of Internal Medicine, The University of Texas at MD Anderson Cancer Center, Houston, Texas, USA; Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
J Biol Chem. 2020 Nov 20;295(47):15840-15852. doi: 10.1074/jbc.RA120.013228. Epub 2020 May 28.
Long noncoding RNAs (lncRNAs) have been shown to play key roles in a variety of biological activities of the cell. However, less is known about how lncRNAs respond to environmental cues and what transcriptional mechanisms regulate their expression. Studies from our laboratory have shown that the lncRNA Tug1 (taurine upregulated gene 1) is crucial for the progression of diabetic kidney disease, a major microvascular complication of diabetes. Using a combination of proximity labeling with the engineered soybean ascorbate peroxidase (APEX2), ChIP-qPCR, biotin-labeled oligonucleotide pulldown, and classical promoter luciferase assays in kidney podocytes, we extend our initial observations in the current study and now provide a detailed analysis on a how high-glucose milieu downregulates Tug1 expression in podocytes. Our results revealed an essential role for the transcription factor carbohydrate response element binding protein (ChREBP) in controlling Tug1 transcription in the podocytes in response to increased glucose levels. Along with ChREBP, other coregulators, including MAX dimerization protein (MLX), MAX dimerization protein 1 (MXD1), and histone deacetylase 1 (HDAC1), were enriched at the promoter under high-glucose conditions. These observations provide the first characterization of the mouse Tug1 promoter's response to the high-glucose milieu. Our findings illustrate a molecular mechanism by which ChREBP can coordinate glucose homeostasis with the expression of the lncRNA Tug1 and further our understanding of dynamic transcriptional regulation of lncRNAs in a disease state.
长链非编码 RNA(lncRNA)已被证明在细胞的多种生物活性中发挥关键作用。然而,人们对 lncRNA 如何响应环境线索以及哪些转录机制调节其表达知之甚少。我们实验室的研究表明,lncRNA Tug1(牛磺酸上调基因 1)对于糖尿病肾病的进展至关重要,糖尿病肾病是糖尿病的一种主要微血管并发症。我们使用工程大豆抗坏血酸过氧化物酶(APEX2)的邻近标记、ChIP-qPCR、生物素标记寡核苷酸下拉和经典启动子荧光素酶测定法,在肾脏足细胞中,扩展了我们在当前研究中的初步观察结果,现在提供了关于高葡萄糖环境如何下调足细胞中 Tug1 表达的详细分析。我们的结果表明,转录因子碳水化合物反应元件结合蛋白(ChREBP)在控制高葡萄糖水平下足细胞中 Tug1 转录中起着重要作用。除了 ChREBP 之外,其他共激活因子,包括 MAX 二聚化蛋白(MLX)、MAX 二聚化蛋白 1(MXD1)和组蛋白去乙酰化酶 1(HDAC1),在高葡萄糖条件下在启动子处富集。这些观察结果首次描述了小鼠 Tug1 启动子对高葡萄糖环境的反应。我们的发现说明了 ChREBP 如何协调葡萄糖稳态与 lncRNA Tug1 的表达,进一步了解疾病状态下 lncRNA 的动态转录调控。